Oppenheimer
OPY | NYSE
$87.92
-$1.33 (-1.49%)
At close: Nov 16, 2026, 4:00 PM ET
$87.92
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 5:54 PM ET
Oppenheimer Company Profile
Company profile explainedCompany Profile
Headquartered in New York since its founding in 1881, Oppenheimer Holdings Inc. serves as a prominent middle-market investment bank and full-service broker-dealer, extending its operations across the Americas, Europe, the Middle East, and Asia. The company provides a comprehensive suite of financial services to a diverse clientele, including affluent individuals, corporate executives, public and private enterprises, institutions, governmental bodies, financial sponsors, and investors globally. Its extensive brokerage offerings cover a wide range of assets, from exchange-traded and over-the-counter corporate equities and debt to money market instruments, options, futures, municipal bonds, mutual funds, exchange-traded funds, and unit investment trusts, complemented by financial planning and wealth management advice, as well as margin lending. Oppenheimer's asset management division delivers tailored investment solutions, encompassing separately managed accounts, discretionary portfolio programs, advisory and consultation services, alternative investments, and specialized fixed income strategies. For businesses and institutions, the firm provides robust investment banking services, including strategic guidance, capital market products, merger and acquisition facilitation, and equity and debt capital market offerings. Additionally, it offers institutional equity services such as sales, trading, research, derivatives, and convertible bond expertise, alongside institutional fixed income sales, trading, research, public finance, and municipal trading. The company's capabilities are further augmented by repurchase agreements, securities lending, proprietary trading, underwriting, market-making, trust, and discount services.
Key Executives
| Name | Position |
|---|---|
| Robert Steven Lowenthal | Chief Executive Officer, President & Director |
| Brad Michael Watkins | Executive Vice President & Chief Financial Officer |
| Albert Grinsfelder Lowenthal | Executive Chairman |
| Dennis Patrick McNamara | Executive Vice President, General Counsel & Secretary |
| Douglas Thornley Siegel | MD & Chief Compliance Officer |
| Manuel Rodriguez | Head of the Latin America Investment Banking Group |
| Peter J. Albano | Senior MD and Global Head of Fixed Income Business - Oppenheimer & Co. Inc. |
| Robin Graham | Head of Technology Investment Banking |
| Rupert Sadler | Managing Director in Technology Investment Banking Group |
| Sean Minnihan | Head of Financial Technology Investment Banking |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 30, 2026 | 8-K | Current Report |
| Oct 30, 2026 | 10-Q | Quarterly Report |
| Aug 03, 2026 | 8-K | Current Report |
| Jul 31, 2026 | 10-Q | Quarterly Report |
| Jul 31, 2026 | 8-K | Current Report |
| Jun 05, 2026 | 11-K | Filing |
| May 11, 2026 | 4 | Filing |
| May 11, 2026 | 4 | Filing |
| May 11, 2026 | 4 | Filing |
| May 11, 2026 | 4 | Filing |
Oppenheimer
| Country | United States |
| IPO Date | Oct 6, 1982 |
| Industry | Financial - Capital Markets |
| Sector | Financial Services |
| Employees | 3,062 |
| CEO | Robert Steven Lowenthal |
Contact Details
85 Broad Street New York City,
New York 10004 United States
Stock Details
| Ticker Symbol | OPY |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000791963 |
| CUSIP Number | 683797104 |
| ISIN Number | US6837971042 |
| SIC Code | 6211 |
Recent News
- 18 days ago / prnewswire.comOppenheimer Holdings Inc. Reports Third Quarter 2026 Earnings
- 1 month ago / fool.comOppenheimer Thinks Viking Therapeutics Stock Can Soar to $120. Here's the Math Behind the Ultra-Bullish Call.
- 2 months ago / benzinga.comFuelCell Energy Stock Surges Following Oppenheimer Initiation: What Investors Need to Know
- 2 months ago / benzinga.com'An AI Operating System, Not a Chatbot': Oppenheimer Hails Microsoft's Enterprise Advantage
- 2 months ago / globenewswire.comCoherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets
- 2 months ago / geekwire.comFrom OK grades to Dartmouth Hall of Fame: Remitly's Matt Oppenheimer on his ‘strengths and shadows'
- 2 months ago / businesswire.comMVB Financial Corp. to Attend the Oppenheimer Fintech Leaders Conference
- 2 months ago / globenewswire.comCoinShares CEO Jean-Marie Mognetti to Attend Oppenheimer Fintech Leaders Conference in New York
- 3 months ago / prnewswire.comOppenheimer Welcomes Joel Berry II and Expands North Carolina Private Client Team Focused on Advising Athletes
- 3 months ago / prnewswire.comOppenheimer Hires Bruce Rideaux and Promotes Lauren Carter As Public Finance Business Continues to Expand
Add to Watchlist
Select watchlists to add or remove OPY